AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,344,000 | +42.0% | 182,301 | 0.0% | 0.01% | +33.3% |
Q3 2016 | $4,468,000 | +2.5% | 182,301 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $4,361,000 | +2.2% | 182,301 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $4,266,000 | +151.1% | 182,301 | +223.9% | 0.01% | +200.0% |
Q4 2015 | $1,699,000 | – | 56,281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |